Satellos Bioscience Inc. (MSLE) stock forecast and price target
Price $6.62 · data as of November 13, 2026
12-month price target
Average target$24.17
Upside / downside+264.8%
Analysts6
ConsensusStrong buy
Low $16.00Average $24.17High $40.00
Gold marker: average target · white marker: today’s price ($6.62)
Analyst ratings
Strong buy 1Buy 8Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-2.15 | −26.6% | $0 |
| Next fiscal year ends December 31, 2027 | $-2.53 | −17.5% | $0 |
| Next quarter ends December 31, 2026 | $-0.57 | −14.5% | $0 |
| Quarter after ends March 31, 2027 | $-0.67 | −25.9% | $0 |
Consensus of the analysts covering Satellos Bioscience, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.
Frequently asked questions
What is the Satellos Bioscience stock price target?
The average 12-month target from 6 analysts is $24.17, 264.8% above the current price of $6.62 Targets range from $16.00 to $40.00.
Is Satellos Bioscience a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 8 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Satellos Bioscience expected to earn?
Analysts expect EPS of $-2.15 for the fiscal year ending December 31, 2026 and $-2.53 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.